<DOC>
	<DOCNO>NCT01887444</DOCNO>
	<brief_summary>The purpose study evaluate efficacy oral administration Lactobacillus reuteri treat infantile colic define Rome III criterion . Forty breastfed infant age 29 day 3 month enrol blind randomized receive orally L.reuteri placebo . The rate responder ( reduction daily cry time &gt; 50 % compare baseline ) assess day 7 , day 14 day 21 group . The average daily cry time well associate digestive symptom also analyze .</brief_summary>
	<brief_title>Lactobacillus Reuteri Supplementation Treatment Infantile Colic</brief_title>
	<detailed_description />
	<mesh_term>Colic</mesh_term>
	<criteria>1 . Exclusively breastfed Infants 2 . Infant age 29 day 3 month 3 . With diagnosis infantile colic define Rome III criteria 4 . Birth term eutrophic ( weight , height , head circumference ) 5 . Apgar score &gt; 7 5 minute 6 . Consent study sign two parent . 7 . Availability study period 1 . Associated severe chronic disease 2 . Acute infectious disease 3 . Personal family first degree history allergy milk proteins 4 . Several infant family multiple pregnancy 5 . Infants receive antibiotic one week prior randomization 6 . Infants receive probiotic one week prior randomization 7 . Mother receive antibiotic 1 week randomization 8 . Regular consumption probiotic mother 1 week randomization 9 . Infantsincluded another clinical study 10 . Lack insurance coverage french social security 11 . Non exclusively breastfed infant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Pediatric Gastroenterology</keyword>
	<keyword>Probiotics</keyword>
	<keyword>Lactobacillus reuteri</keyword>
</DOC>